Literature DB >> 19509286

A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.

Kamalpreet Nagpal1, Theo S Plantinga, Joyce Wong, Brian G Monks, Nicholas J Gay, Mihai G Netea, Katherine A Fitzgerald, Douglas T Golenbock.   

Abstract

The adapter protein MyD88 adapter-like (Mal), encoded by TIR-domain containing adapter protein (Tirap) (MIM 606252), is the most polymorphic of the five adapter proteins involved in Toll-like receptor signaling, harboring eight non-synonymous single nucleotide polymorphisms in its coding region. We screened reported mutations of Mal for activity in reporter assays to test the hypothesis that variants of Mal existed with altered signaling potential. A TIR domain variant, Mal D96N (rs8177400), was found to be inactive. In reconstituted cell lines, Mal D96N acted as a hypomorphic mutation, with impaired cytokine production and NF-kappaB activation upon lipopolysaccharide or PAM2CSK4 stimulation. Moreover, co-immunoprecipitation studies revealed that Mal D96N is unable to interact with MyD88, a prerequisite for downstream signaling to occur. Computer modeling data suggested that residue 96 resides in the MyD88 binding site, further supporting these findings. Genotyping of Mal D96N in three different cohorts suggested that it is a rare mutation. We, thus, describe a rare variant in Mal that exerts its effect via its inability to bind MyD88.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19509286      PMCID: PMC2757976          DOI: 10.1074/jbc.M109.014886

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Hideki Sanjo; Satoshi Uematsu; Tsuneyasu Kaisho; Katsuaki Hoshino; Osamu Takeuchi; Masaya Kobayashi; Takashi Fujita; Kiyoshi Takeda; Shizuo Akira
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

2.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

3.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

Review 4.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.

Authors:  Stefanie N Vogel; Katherine A Fitzgerald; Matthew J Fenton
Journal:  Mol Interv       Date:  2003-12

5.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

6.  RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.

Authors:  Etienne Meylan; Kim Burns; Kay Hofmann; Vincent Blancheteau; Fabio Martinon; Michelle Kelliher; Jürg Tschopp
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

7.  TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA.

Authors:  Marie Charrel-Dennis; Eicke Latz; Kristen A Halmen; Patrick Trieu-Cuot; Katherine A Fitzgerald; Dennis L Kasper; Douglas T Golenbock
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

Review 8.  The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.

Authors:  Anne F McGettrick; Luke A J O'Neill
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

9.  Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections.

Authors:  Andrei E Medvedev; Arnd Lentschat; Douglas B Kuhns; Jorge C G Blanco; Cindy Salkowski; Shuling Zhang; Moshe Arditi; John I Gallin; Stefanie N Vogel
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Betsy J Barnes; Daniel R Caffrey; Alberto Visintin; Eicke Latz; Brian Monks; Paula M Pitha; Douglas T Golenbock
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  27 in total

1.  Meet me halfway: when genomics meets structural bioinformatics.

Authors:  Sungsam Gong; Catherine L Worth; Tammy M K Cheng; Tom L Blundell
Journal:  J Cardiovasc Transl Res       Date:  2011-02-25       Impact factor: 4.132

2.  Restricting HIV the SAMHD1 way: through nucleotide starvation.

Authors:  Diana Ayinde; Nicoletta Casartelli; Olivier Schwartz
Journal:  Nat Rev Microbiol       Date:  2012-08-28       Impact factor: 60.633

3.  R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

Authors:  Yanbao Xiong; Chang Song; Greg A Snyder; Eric J Sundberg; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

4.  The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.

Authors:  Leandra Figueroa; Yanbao Xiong; Chang Song; Wenji Piao; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

5.  ARC Syndrome-Linked Vps33B Protein Is Required for Inflammatory Endosomal Maturation and Signal Termination.

Authors:  Mohammed Ali Akbar; Rajakumar Mandraju; Charles Tracy; Wei Hu; Chandrashekhar Pasare; Helmut Krämer
Journal:  Immunity       Date:  2016-08-02       Impact factor: 31.745

6.  A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.

Authors:  Hui Wang; Sinead M Flannery; Sabine Dickhöfer; Stefanie Huhn; Julie George; Andriy V Kubarenko; Jesus Lascorz; Melanie Bevier; Joschka Willemsen; Tica Pichulik; Clemens Schafmayer; Marco Binder; Bénédicte Manoury; Søren R Paludan; Marta Alarcon-Riquelme; Andrew G Bowie; Asta Försti; Alexander N R Weber
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

7.  The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.

Authors:  David Torres; Sandrine Delbauve; Ezra Aksoy; Salma Taboubi; Abderrahman Hachani; Maria A Whitehead; Wayne P Pearce; Inma M Berenjeno; Gemma Nock; Alain Filloux; Rudi Beyaert; Veronique Flamand; Bart Vanhaesebroeck
Journal:  Nat Immunol       Date:  2012-09-30       Impact factor: 25.606

8.  Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells.

Authors:  Junfei Jin; Devadoss J Samuvel; Xiaoming Zhang; Yanchun Li; Zhongyang Lu; Maria F Lopes-Virella; Yan Huang
Journal:  Mol Immunol       Date:  2011-10-26       Impact factor: 4.407

9.  A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction.

Authors:  Kevin S Bonham; Megan H Orzalli; Kachiko Hayashi; Amaya I Wolf; Christoph Glanemann; Wolfgang Weninger; Akiko Iwasaki; David M Knipe; Jonathan C Kagan
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

10.  The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling.

Authors:  Tim Van Acker; Sven Eyckerman; Lieselotte Vande Walle; Sarah Gerlo; Marc Goethals; Mohamed Lamkanfi; Celia Bovijn; Jan Tavernier; Frank Peelman
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.